Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-130368
Filing Date
2016-07-01
Accepted
2016-07-01 11:43:16
Documents
1
Period of Report
2016-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5492
  Complete submission text file 0001209191-16-130368.txt   6856
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address
Baldwin John J. (Reporting) CIK: 0001589786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 161745531